Profile of darunavir in the management of treatment-experienced HIV patients

about

Enhancing protein backbone binding--a fruitful concept for combating drug-resistant HIV.

P2860

Q37980084-340D3290-A400-4DF8-AF4E-973346CB3ABA

P2860

Profile of darunavir in the management of treatment-experienced HIV patients

Item

http://www.wikidata.org/entity/Q35557212

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Profile of darunavir in the management of treatment-experienced HIV patients

@ast

Profile of darunavir in the management of treatment-experienced HIV patients

@en

type

Item

label

Profile of darunavir in the management of treatment-experienced HIV patients

@ast

Profile of darunavir in the management of treatment-experienced HIV patients

@en

prefLabel

Profile of darunavir in the management of treatment-experienced HIV patients

@ast

Profile of darunavir in the management of treatment-experienced HIV patients

@en

P1476

Profile of darunavir in the management of treatment-experienced HIV patients

@en

P2093

Cameron Wolfe

http://www.w3.org/2001/XMLSchema#string

Charles Hicks

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Flap Mutations on Structure of HIV-1 Protease and Inhibition by Saquinavir and Darunavir

Raltegravir with optimized background therapy for resistant HIV-1 infection

Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals.

Natural history of HIV infection in the era of combination antiretroviral therapy.

Solution kinetics measurements suggest HIV-1 protease has two binding sites for darunavir and amprenavir.

Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro.

Clinical pharmacokinetics of darunavir.

Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.

Emerging resistance profiles of newly approved antiretroviral drugs.

Update of the Drug Resistance Mutations in HIV-1.

P304

13-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/HIV.S4842

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22096376

http://www.w3.org/2001/XMLSchema#string

P932

3218680

http://www.w3.org/2001/XMLSchema#string

Profile of darunavir in the management of treatment-experienced HIV patients

about

P2860

P2860

Profile of darunavir in the management of treatment-experienced HIV patients

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P577

P698

P932